New Terumo–Tata Elxsi Center to Accelerate AI-powered Medical Device Innovation

Tata Elxsi, a global leader in design and technology services, and Terumo Corporation, a leading medical innovation company, have inaugurated the Terumo–Tata Elxsi Offshore Development Center. The new facility is dedicated to advancing cardiac and vascular solutions, strengthening engineering and innovation capabilities, and providing continuous lifecycle support across international markets.

Driving Next-Gen Medical Technologies

The center brings together multidisciplinary teams, combining Tata Elxsi’s expertise in design, engineering, verification, regulatory compliance, and localisation with cutting-edge applications of AI, GenAI, and digital technologies in software engineering. This integrated approach enables faster product development, regional adaptation, and improved cost efficiency while addressing the growing demand for patient-centric medical devices.

Enhancing Global Availability

By leveraging Tata Elxsi’s cross-functional capabilities, the collaboration aims to improve the reliability and performance of cardiovascular technologies, ensuring they meet stringent industry standards and the evolving needs of healthcare providers and patients worldwide.

Fumihisa Hirose, President of Terumo’s Cardiac & Vascular Company, emphasized the strategic importance of the center: “This new Offshore Development Center strengthens our ability to innovate faster and deliver high-quality medical technologies across global markets. Tata Elxsi’s integrated design, engineering, and regulatory expertise will help us accelerate our global product roadmap while maintaining the highest standards of safety and compliance.”

Sreevatsa Sahasranaman, Senior Vice President & Head – Healthcare & Life Sciences at Tata Elxsi, highlighted the long-term vision: "This Offshore Development Center represents a comprehensive partnership model with Terumo to bring Tata Elxsi’s multi-disciplinary expertise to drive innovation and cost efficiencies across Terumo’s cardiovascular portfolio. Enhanced by AI and GenAI-powered technologies, we are committed to helping Terumo deliver next-gen medical technologies to global and emerging markets.”

Strategic Impact

The collaboration marks a significant milestone in the healthcare technology sector, reinforcing India’s role as a hub for advanced engineering and design services while supporting Terumo’s mission to deliver innovative cardiovascular solutions worldwide.